Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advocates For Switching Birth Control Pill Face Social, Risk Obstacles

This article was originally published in The Tan Sheet

Executive Summary

A women's health advocacy group that hopes to meet with FDA within the next year to explore potentially switching oral contraceptives to OTC may be hard-pressed to find a pharmaceutical company interested in sponsoring such a venture
Advertisement

Related Content

Physician Group Support Boosts OTC Contraception Chances
Physician Group Support Boosts OTC Contraception Chances
Teva Opposes Switching Asthma Drugs, Oral Contraceptives
Teva Opposes Switching Asthma Drugs, Oral Contraceptives
Birth Control Primed For Switch
Birth Control Primed For Switch
Teva Plan B OTC Application Fails Political Test After Clearing FDA Hurdle
Benefits, Pitfalls Of OTC Birth Control Apparent In Cross-Border Study
FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”
FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”

Topics

Advertisement
UsernamePublicRestriction

Register

PS104324

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel